Clinical Trial Update: EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating external beam radiotherapy and high-dose-rate brachytherapy for unfavorable-intermediate, high, and very high-risk prostate cancer is a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Snippet

Sponsor: University of Virginia | Conditions: Prostate Cancer, Prostate Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING